Alcon Introduces New Systane(R) BALANCE Lubricant Eye Drops for Dry Eye Patients with Meibomian Gland Dysfunction
HUENENBERG, Switzerland, Oct 11, 2010 (BUSINESS WIRE) --
Alcon, Inc. (NYSE: ACL), the world's leader in eye care, announced the launch of Systane(R) BALANCE Lubricant Eye Drops, the newest lubricant eye drop in the Systane(R) family of products. Patients with Meibomian Gland Dysfunction (MGD) are unable to adequately prevent the evaporation of tears, resulting in dry eye symptoms. Systane(R) BALANCE is a scientifically engineered product that contains HP Guar, borate, sorbitol, propylene glycol and Alcon's exclusive LipiTech(TM) System, a unique emulsion technology of mineral oil and an anionic phospholipid. Systane(R) BALANCE is designed to restore the lipid layer and the natural tear film to allow for relief of dry eye symptoms.
"We are dedicated to applying scientific rigor to discover treatments for chronic conditions such as dry eye. Meibomian Gland Dysfunction is a significant cause of dry eye symptoms and now patients who suffer from dry eye associated with MGD can use Systane(R) BALANCE to restore their lipid layer, re-establish their natural tear film and maintain their tear film stability," said Sabri Markabi, M.D., Alcon's chief medical officer and senior vice president of Research and Development.
No comments:
Post a Comment